Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 6/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.43 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.43 |
| ▸ | CHRNG | P07510 | 4/20 | 0.43 |
| ▸ | CHRNB1 | P11230 | 4/20 | 0.43 |
| ▸ | CHRND | Q07001 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10939615 | 1.00 | DPP7 (0.45) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL14511335 | 1.00 | DPP7 (0.45) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL2792423 | 1.00 | DPP7 (0.45) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL4938808 | 1.00 | DPP7 (0.45) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL8776616 | 0.98 | GAA (0.46) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL3749068 | 0.98 | GAA (0.46) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL500405 | 0.97 | ALDH1A1 (0.42) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL30678696 | 0.97 | ALDH1A1 (0.42) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| SCHEMBL4939151 | 0.97 | ALDH1A1 (0.42) | DPP7MAOBSLC6A2CHRNB4CHRNA3 | |
| Hydrochloric Acid SCHEMBL28356462 | 0.95 | LMNA (0.44) | DPP7MAOBSLC6A2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12551418-B2 | Cosmetic containing ultraviolet wavelength converting substance and medicinal agent | SHISEIDO COMPANY, LTD. (JP) | 2026-02-17 | — | — | US | claimed |
| EP-4003346-B1 | THE SERPINB3 INHIBITOR PIPERIDINEPROPIONIC ACID FOR TUMOR TREATMENT | UNIV DEGLI STUDI PADOVA (IT) | 2025-09-03 | — | — | EP | claimed |
| WO-2025094676-A1 | COMPOSITION CONTAINING 1-PIPERIDINEPROPIONIC ACID AND GERANIUM THUNBERGII | 株式会社 資生堂 | 2025-05-08 | — | — | WO | claimed |
| CN-119781248-A | Negative photoresist composition and patterning method | 阜阳欣奕华新材料科技股份有限公司 | 2025-04-08 | — | — | CN | claimed |
| US-20250082559-A1 | EXTERNAL-USE SKIN PREPARATION COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2025-03-13 | — | — | US | claimed |
| US-20250041188-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2025-02-06 | — | — | US | claimed |
| US-20240423890-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2024-12-26 | — | — | US | claimed |
| EP-4473958-A1 | SKIN CARE COMPOSITION | Shiseido Company, Ltd. (JP) | 2024-12-11 | — | — | EP | claimed |
| EP-4442325-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2024-10-09 | — | — | EP | claimed |
| EP-4442242-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2024-10-09 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| EP-0673782-A2 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0471592-B1 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | DOW CHEMICAL CO (US) | 1995-08-09 | — | — | EP | claimed |
| US-5236678-A | Process for absorption of sulfur compounds from fluids using piperidines | THE DOW CHEMICAL COMPANY (US) | 1993-08-17 | — | — | US | claimed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | claimed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| EP-0471592-A2 | Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids | THE DOW CHEMICAL COMPANY (US) | 1992-02-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041188-A1 | COSMETIC | GLA, ASAH2, SORD | DPP7 3269/4885MAOB 2702/4885SLC6A2 2854/4885 |
| US-20250082559-A1 | EXTERNAL-USE SKIN PREPARATION COMPOSITION | TYR, CUTA, NACA | DPP7 157/4885MAOB 40/4885SLC6A2 378/4885 |
| US-20240423890-A1 | COSMETIC | TYR, RBP1, NISCH | DPP7 4365/4885MAOB 224/4885SLC6A2 495/4885 |
| US-12551418-B2 | Cosmetic containing ultraviolet wavelength converting substance and medicinal agent | GLA, PGA5, AGER | DPP7 1369/4885MAOB 970/4885SLC6A2 3665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.